Jason Grebely, PhD; Gregory J. Dore, MBBS, PhD; Robert Greenwald, JD; Tracy Swan; Soumitri Barua; Lynn E. Taylor, MD
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L15-0485.
Financial Support: The Kirby Institute is funded by the Australian Government Department of Health and Ageing. Dr. Grebely is supported by a National Health and Medical Research Council Career Development Fellowship. Mr. Greenwald is supported by Harvard Law School. Dr. Taylor is supported by a Rhode Island Innovation Fellowship from the Rhode Island Foundation for her Rhode Island Defeats Hep C project and the Lifespan/Tufts/Brown Center for AIDS Research (grant P30AI042853 from the National Institute of Allergy and Infectious Diseases). Ms. Barua was supported by the Lifespan/Tufts/Brown Center for AIDS Research Summer Student Internship program (grant P30AI042853).
Learn more about subscription options.
Register Now for a free account.
Grebely J, Dore GJ, Greenwald R, Swan T, Barua S, Taylor LE. Hepatitis C Virus Treatment and Persons Who Inject Drugs. Ann Intern Med. 2016;164:203. doi: 10.7326/L15-0485
Download citation file:
Published: Ann Intern Med. 2016;164(3):203.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only